WallStSmart
PROF

Profound Medical Corp

NASDAQ: PROF · HEALTHCARE · MEDICAL DEVICES

$7.25
+3.66% today

Updated 2026-06-04

Market cap
$237.65M
P/E ratio
P/S ratio
12.63x
EPS (TTM)
$-1.24
Dividend yield
52W range
$4 – $9
Volume
0.1M

Profound Medical Corp (PROF) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20122013201420152016201720182019202020212022202320242025
Operating cash flow$-3.01M$-3.17M$-2.88M$-4.94M$-10.79M$-14.85M$-13.43M$-15.45M$-20.57M$-22.36M$-25.80M$-22.61M$-23.45M$-38.88M
Capital expenditures$216332.00$79721.00$61283.00$120350.00$808842.00$369502.00$32000.00$2.00$350000.00$593000.00$0.00$1.00$0.00$179084.00
Depreciation$84896.00$85772.00$139132.00$693310.00$1.23M$1.55M$1.54M$1.88M$1.60M$929000.00$936000.00
Stock-based comp$273186.00$218552.00$190333.00$464608.00$745151.00$1.06M$797485.00$1.28M$3.02M$7.21M$4.24M$3.42M$2.58M$5.49M
Free cash flow$-3.23M$-3.25M$-2.94M$-5.06M$-11.60M$-15.22M$-13.46M$-15.45M$-20.92M$-22.95M$-25.80M$-22.61M$-23.45M$-39.05M
Investing cash flow$-61283.00$-6.49M$6.63M$-793183.00$-189000.00$-192789.00$-350000.00$-593000.00
Financing cash flow$2.74M$18.73M$11.83M$6.12M$27.81M$6.80M$87.43M$5.95M$7.03M$1.76M$54.70M
Dividends paid$0.00$0.00
Share repurchases
Debt repayment
Net change in cash$0.00

Frequently asked questions

What is Profound Medical Corp's revenue?

Profound Medical Corp's trailing twelve-month revenue is $18.81M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is PROF?

In its most recent fiscal year, PROF ran a gross margin of 70.77%, an operating margin of -256.27%, and a net margin of -264.44%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does PROF generate?

PROF produced $-39.05M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is PROF's balance sheet healthy?

PROF holds $81.80M in cash and equivalents against $4.50M in long-term debt, on $90.99M of shareholder equity. Cash on hand exceeds long-term debt, so the balance sheet adds little financial risk to the thesis.